GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bionoid Pharma Inc (OTCPK:BINP) » Definitions » LT-Debt-to-Total-Asset

Bionoid Pharma (Bionoid Pharma) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2011)


View and export this data going back to 2007. Start your Free Trial

What is Bionoid Pharma LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Bionoid Pharma's long-term debt to total assests ratio for the quarter that ended in Mar. 2011 was 0.00.

Bionoid Pharma's long-term debt to total assets ratio stayed the same from Mar. 2010 (0.00) to Mar. 2011 (0.00).

Bionoid Pharma LT-Debt-to-Total-Asset Historical Data

The historical data trend for Bionoid Pharma's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionoid Pharma LT-Debt-to-Total-Asset Chart

Bionoid Pharma Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
LT-Debt-to-Total-Asset
0.08 - - - -

Bionoid Pharma Quarterly Data
Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bionoid Pharma LT-Debt-to-Total-Asset Calculation

Bionoid Pharma's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2010 is calculated as

LT Debt to Total Assets (A: Dec. 2010 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2010 )/Total Assets (A: Dec. 2010 )
=0/1.33
=

Bionoid Pharma's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2011 is calculated as

LT Debt to Total Assets (Q: Mar. 2011 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2011 )/Total Assets (Q: Mar. 2011 )
=0/0.647
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionoid Pharma  (OTCPK:BINP) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Bionoid Pharma LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Bionoid Pharma's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionoid Pharma (Bionoid Pharma) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bionoid Pharma Inc (OTCPK:BINP) » Definitions » LT-Debt-to-Total-Asset
Comparable Companies
DXTR NURO PEYE ECIA RSCF SSKN SOAN ASNB UNISQ WHSI QTXB LSE:AKR SKLN UEEC NEPH STXS REPR ATEC WAR:MMD DXR
Traded in Other Exchanges
N/A
Address
433 N Camden Dr, Beverly Hills, CA, USA, 90210
Website
https://www.bionoidpharma.com
Bionoid Pharma Inc is a cannabis company that cultivates, extracts, tests, and distributes organic hemp, cannabinoid, and related products. Its products aid in decreasing pain, improving recovery time, enhancing performance, and enhance physical well-being.